Vanda Pharmaceuticals (VNDA) Tops Q2 EPS by 12c
Tweet
Share
E-mailGet Alerts VNDA Hot Sheet
Price: $5.95 -0.83%
Revenue Growth %: +17.5%
Financial Fact:
Intangible asset amortization: 2.94M
Today's EPS Names:
CBRS, MAYS, CRMT, More
Revenue Growth %: +17.5%
Financial Fact:
Intangible asset amortization: 2.94M
Today's EPS Names:
CBRS, MAYS, CRMT, More
Join SI Premium – FREE
Vanda Pharmaceuticals (NASDAQ: VNDA) reported Q2 EPS of ($0.11), $0.12 better than the analyst estimate of ($0.23).
For earnings history and earnings-related data on Vanda Pharmaceuticals (VNDA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- CVG to join Russell 2000 and Russell 3000 indexes June 26
- Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
